» Articles » PMID: 26378152

LKB1 Deletion Causes Early Changes in Atrial Channel Expression and Electrophysiology Prior to Atrial Fibrillation

Overview
Journal Cardiovasc Res
Date 2015 Sep 18
PMID 26378152
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Liver kinase B1 (LKB1) is a protein kinase that activates the metabolic regulator AMP-activated protein kinase (AMPK) and other related kinases. Deletion of LKB1 in mice leads to cardiomyopathy and atrial fibrillation (AF). However, the specific role of the LKB1 pathway in early atrial biology remains unknown. Thus, we investigated whether LKB1 deletion altered atrial channel expression and electrophysiological function in a cardiomyocyte-specific knockout mouse model.

Methods And Results: We performed a systematic comparison of αMHC-Cre LKB1(fl/fl) and littermate LKB1(fl/fl) male mice. This included analysis of gene expression, histology, and echocardiography, as well as cellular and tissue-level electrophysiology using patch-clamp recordings in vitro, optical mapping ex vivo, and ECG recordings in vivo. At postnatal day 1, atrial depolarization was prolonged, and Nav1.5 and Cx40 expression were markedly down-regulated in MHC-Cre LKB1(fl/fl) mice. Inward sodium current density was significantly decreased in MHC-Cre LKB1(fl/fl) neonatal atrial myocytes. Subsequently, additional alterations in atrial channel expression, atrial fibrosis, and spontaneous onset of AF developed by 2 weeks of age. In adult mice, abnormalities of interatrial conduction and bi-atrial electrical coupling were observed, likely promoting the perpetuation of AF. Mice with AMPK-inactivated hearts demonstrated modest overlap in channel expression with MHC-Cre LKB1(fl/fl) hearts, but retained normal structure, electrophysiological function and contractility.

Conclusions: Deletion of LKB1 causes early defects in atrial channel expression, action potential generation and conduction, which precede widespread atrial remodelling, fibrosis and AF. LKB1 is critical for normal atrial growth and electrophysiological function.

Citing Articles

Investigating Left Atrial Diameter and Heart Failure Onset in Middle-Aged and Elderly: A Retrospective-Prospective Study.

Wang A, Hu H, Zhang D, Qian G, Pan H, Zhai C Clin Cardiol. 2025; 48(3):e70085.

PMID: 40051296 PMC: 11885888. DOI: 10.1002/clc.70085.


Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American....

Goette A, Corradi D, Dobrev D, Aguinaga L, Cabrera J, Chugh S Europace. 2024; 26(9).

PMID: 39077825 PMC: 11431804. DOI: 10.1093/europace/euae204.


Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights.

Sarkar A, Fanous K, Marei I, Ding H, Ladjimi M, MacDonald R Vasc Health Risk Manag. 2024; 20:255-288.

PMID: 38919471 PMC: 11198029. DOI: 10.2147/VHRM.S391808.


Cannabinoid receptor agonist attenuates angiotensin II-induced enlargement and mitochondrial dysfunction in rat atrial cardiomyocytes.

Altieri D, Etzion Y, Anderson H Front Pharmacol. 2023; 14:1142583.

PMID: 37113758 PMC: 10126395. DOI: 10.3389/fphar.2023.1142583.


Mouse models of spontaneous atrial fibrillation.

Keefe J, Hulsurkar M, Reilly S, Wehrens X Mamm Genome. 2022; 34(2):298-311.

PMID: 36173465 PMC: 10898345. DOI: 10.1007/s00335-022-09964-x.


References
1.
Gollob M, Green M, Tang A, Gollob T, Karibe A, Ali Hassan A . Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med. 2001; 344(24):1823-31. DOI: 10.1056/NEJM200106143442403. View

2.
Ozcan C, Battaglia E, Young R, Suzuki G . LKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process. J Am Heart Assoc. 2015; 4(3):e001733. PMC: 4392447. DOI: 10.1161/JAHA.114.001733. View

3.
Nakajima H, Nakajima H, Salcher O, Dittie A, Dembowsky K, Jing S . Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. Circ Res. 2000; 86(5):571-9. DOI: 10.1161/01.res.86.5.571. View

4.
Papadatos G, Wallerstein P, Head C, Ratcliff R, Brady P, Benndorf K . Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci U S A. 2002; 99(9):6210-5. PMC: 122928. DOI: 10.1073/pnas.082121299. View

5.
Bardeesy N, Sinha M, Hezel A, Signoretti S, Hathaway N, Sharpless N . Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature. 2002; 419(6903):162-7. DOI: 10.1038/nature01045. View